PETROSCRAPS.COM

Elixir Medical Corporation Announces Excellent Nine Month Safety And Efficacy Results From The EXCELLA II Randomized …
Elixir Medical Corporation, a developer of product platforms combining state-of-the-art medical devices with advanced pharmaceuticals, announced today the superiority of the Elixir DESyne stent compared to the control Endeavor stent in the primary endpoint of the EXCELLA II randomized clinical trial. The Elixir DESyne Stent is the first drug eluting stent with the thinnest durable polymer …

Read more on Medical News Today

This entry was posted on Tuesday, June 1st, 2010 at 7:35 pm and is filed under Polymer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.